HAE – haemonetics corporation (US:NASDAQ)
Stock Stats
News
Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
Haemonetics Co. (NYSE: HAE) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $108.00 price target on the stock.
Is Haemonetics Corporation (HAE) an Undervalued Healthcare Stock to Buy in 2025 [Yahoo! Finance]
Haemonetics Co. (NYSE: HAE) is now covered by analysts at CL King. They set a "buy" rating and a $116.00 price target on the stock.
Haemonetics Co. (NYSE: HAE) is now covered by analysts at Bank of America Co.. They set a "neutral" rating and a $85.00 price target on the stock.
Form 4 HAEMONETICS CORP For: Nov 01 Filed by: Galvin Roy
Form 4 HAEMONETICS CORP For: Sep 17 Filed by: Miller Laurie A.
Form 8-K HAEMONETICS CORP For: Sep 10
Form 4 HAEMONETICS CORP For: Aug 29 Filed by: Simon, Christopher
Form 10-Q HAEMONETICS CORP For: Jun 29
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.